Asymptomatic Left Ventricular Systolic Dysfunction (Stage B Heart Failure) and Response to Chronic Protein Therapy With SQ BNP

被引：0
|
作者：
McKie, Paul M. [1 ]
Schirger, John A. [1 ]
Cataliotti, Alessandro [1 ]
Simari, Robert A. [1 ]
Redfield, Margaret M. [1 ]
Burnett, John C. [1 ]
Chen, Horng C. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Heart failure; Natriuretic peptide; Pharmacology; Kidney; Prevention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14335
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Stage B heart failure - Management of asymptomatic left ventricular systolic dysfunction
    Goldberg, Lee R.
    Jessup, Mariell
    CIRCULATION, 2006, 113 (24) : 2851 - 2860
  • [2] Cardiorenal Response to Acute Volume Loading in Human Preclinical Diastolic Dysfunction (Stage B Heart Failure) After 12 weeks of Chronic SQ BNP Administration
    Wan, Siu-Hin
    McKie, Paul M.
    Schirger, John A.
    Cataliotti, Alessandro
    Simari, Robert D.
    Redfield, Margaret M.
    Burnett, John C.
    Chen, Horng H.
    CIRCULATION, 2013, 128 (22)
  • [3] The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population
    Thackray, SDR
    Witte, KKA
    Nikitin, NP
    Clark, AL
    Kaye, GC
    Cleland, JGF
    EUROPEAN HEART JOURNAL, 2003, 24 (12) : 1143 - 1152
  • [4] Effectiveness of β-Blockers in Heart Failure With Left Ventricular Systolic Dysfunction and Chronic Kidney Disease
    Chang, Tara I.
    Yang, Jingrong
    Freeman, James V.
    Hlatky, Mark A.
    Go, Alan S.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (03) : 176 - 182
  • [5] Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction
    Murtagh, Gillian
    Dawkins, Ian R.
    O'Connell, Ronan
    Badabhagni, Mallikarjuna
    Patel, Anil
    Tallon, Elaine
    O'Hanlon, Rory
    Ledwidge, Mark T.
    McDonald, Kenneth M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (05) : 480 - 486
  • [6] Diuretic Therapy in Elderly Heart Failure Patients With and Without Left Ventricular Systolic Dysfunction
    Dave J. W. van Kraaij
    René W. M. M. Jansen
    Frank W. J. Gribnau
    Willibrord H. L. Hoefnagels
    Drugs & Aging, 2000, 16 : 289 - 300
  • [7] Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure
    Aleksova, Aneta
    Masson, Serge
    Maggioni, Aldo P.
    Lucci, Donata
    Urso, Renato
    Staszewsky, Lidia
    Ciaffoni, Stefano
    Cacciatore, Giuseppe
    Misuraca, Gianfranco
    Gulizia, Michele
    Mos, Lucio
    Proietti, Gianni
    Minneci, Calogero
    Latini, Roberto
    Sinagra, Gianfranco
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (02) : 131 - 143
  • [8] Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure
    Aneta Aleksova
    Serge Masson
    Aldo P. Maggioni
    Donata Lucci
    Renato Urso
    Lidia Staszewsky
    Stefano Ciaffoni
    Giuseppe Cacciatore
    Gianfranco Misuraca
    Michele Gulizia
    Lucio Mos
    Gianni Proietti
    Calogero Minneci
    Roberto Latini
    Gianfranco Sinagra
    Cardiovascular Drugs and Therapy, 2012, 26 : 131 - 143
  • [9] Heart rate control in patients with left ventricular systolic dysfunction and heart failure
    Pourdjabbar, Ali
    Dwivedi, Girish
    Haddad, Ruba
    Saikali, Anthony
    Mielniczuk, Lisa
    Haddad, Haissam
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 276 - 277
  • [10] Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction
    Haworth, JE
    Moniz-Cook, E
    Clark, AL
    Wang, M
    Waddington, R
    Cleland, JGF
    EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (05) : 803 - 808
12345